Form 4: 89bio CFO Ryan Martins Reports Stock Transaction
SEC Form 4 Filing
Ryan Martins, CFO of 89bio, Inc., reports the disposal of 777 common stock shares to cover tax obligations related to vesting restricted stock units.
Summary
- On August 17, 2024, Ryan Martins, the Chief Financial Officer of 89bio, Inc. (ETNB), reported a transaction involving the company's common stock.
- Martins disposed of 777 shares of common stock at a price of $8.04 per share.
- This transaction was executed to cover the estimated tax withholding obligation associated with the vesting of restricted stock units.
- Following the transaction, Martins beneficially owns 105,832 shares of 89bio, Inc.
Sentiment
Score: 5
Explanation: Neutral sentiment as it's a standard transaction related to executive compensation and tax obligations.
Industry Context
This is a routine disclosure related to executive compensation and tax obligations, common in publicly traded companies.
Stakeholder Impact
- The transaction has a minimal impact on stakeholders as it is a routine sale of shares to cover tax obligations.
Key Dates
| Date | Description |
|---|---|
| 08/17/2024 | Date of the stock transaction (disposal of shares). |
| 08/19/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.